Update date: Jul 14, 2026 | 267 Pages | Report ID: PPS-PS-007551
Sachet Packaging for Pharmaceuticals Market
DMA IntelligenceSachet Packaging for Pharmaceuticals Growth Drivers & Industry Outlook 2033
Segments: Material Type (Plastic, Paper, Aluminum Foil, Others), Product Type (Single-use Sachets, Multi-use Sachets), Application (Tablets & Capsules, Powders, Liquids, Others), End-User (Hospitals, Clinics, Retail Pharmacies, Others), Distribution Channel (Direct Sales, Distributors, Online Sales, Others), By Region, And Segment Forecasts
$7.4B
Market Size, 2025
$7.9B
Market Estimate, 2026
$12.0B
Market Forecast, 2033
6.2%
CAGR, 2026–2033
Sachet Packaging for Pharmaceuticals Market Size, Share & Key Insights
The Sachet Packaging for Pharmaceuticals Market size was valued at USD 7.40 in 2025, and the market is projected to grow from USD 7.86 in 2026 to USD 11.97 by 2033, growing at a CAGR of 6.2%% during the forecast period 2026–2033. North America, Europe, APAC, Latin America, MEA led the global market in 2025.
Study Overview
 Study Period | 2021 - 2033 |
 Base Year | 2025 |
 Estimated Year | 2026 |
 Forecast Period | 2026-2033 |
 Historical Range | 2021-2025 |
| Units | USD Billion |
 Coverage | Global | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
 Deliverables | PDF + Excel Data Pack |
Major Market Players
Key Takeaways: Sachet Packaging for Pharmaceuticals Market
- In 2025, the global Sachet Packaging for Pharmaceuticals market size was estimated to be USD 7.40 Billion
- Projected to grow at a 6.2% CAGR, reaching a valuation of USD 12.03 Billion by 2033
- The Powders category accounted for the highest market share of 40% within the Application segment
- Granules captured a substantial 25% of the total revenue in 2025
- Regionally, Asia Pacific emerged as the top market, generating USD 2.59 Billion and securing a 35% share
- Primary market growth drivers include increasing demand for unit-dose packaging, rising geriatric population, and advancements in packaging materials
- Key industry player Amcor plc strengthened its market position via strategic partnerships and product innovation focusing on sustainable solutions
Market Definiton and Strategic Context
The Sachet Packaging for Pharmaceuticals Market refers to the specialized segment of the packaging industry focused on producing small, flexible pouches designed to hold single or multiple doses of pharmaceutical products. These sachets are typically made from various materials like plastic films, paper, and aluminum foil, often in multi-layered laminates, to ensure product integrity, protection from moisture and light, and ease of use. The market encompasses a wide range of applications, including packaging for powders, granules, liquids, and pastes, catering to diverse end-users such as pharmaceutical companies, contract manufacturing organizations (CMOs), retail pharmacies, and hospitals & clinics. The growing demand for convenient, portable, and accurately dosed medication forms is a primary driver for this market. Sachet packaging offers several advantages, including improved patient compliance due to pre-measured doses, enhanced product stability, reduced material usage compared to traditional bottling, and cost-effectiveness in transportation and storage. The global Sachet Packaging for Pharmaceuticals market size was estimated at USD 7.40 Billion in 2025, reflecting a robust industry expansion driven by increasing pharmaceutical production, rising prevalence of chronic diseases necessitating convenient medication formats, and advancements in packaging technologies. This market is poised for significant growth, with a strong market forecast indicating continued upward trajectory. Innovations in sustainable materials and advanced barrier properties are further shaping the industry's outlook. The report delves into the intricate dynamics influencing this sector, providing a comprehensive analysis of growth drivers, restraints, opportunities, and challenges, along with a detailed competitive landscape and regional insights to offer a holistic understanding of the Sachet Packaging for Pharmaceuticals market.
| Report Attribute | Details |
|---|---|
| Market size value in 2025 | USD 7.40 Billion |
| Revenue forecast in 2033 | USD 11.97 Billion |
| Growth rate | CAGR of 6.2% from 2025 to 2033 |
| Actual data | 2021 - 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD Billion and CAGR from 2025 to 2033 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | Material Type, Product Type, Application, End-User, Distribution Channel |
| Regional scope | North America; Europe; Asia Pacific; Rest of Asia Pacific; Latin America; Middle East & Africa |
| Country scope | United States; Canada; Germany; France; Italy; United Kingdom; Spain; Russia; Rest of Europe; China; Japan; South Korea; India; Australia; South East Asia (SEA; All; Mexico; Brazil; Rest of Latin America; Saudi Arabia; South Africa; United Arab Emirates; Rest of Middle East & Africa |
| Key companies profiled | Amcor plc; Constantia Flexibles Group GmbH; Glenroy Inc.; ProAmpac; Huhtamaki Group; Mondi Group; Sealed Air Corporation; Sonoco Products Company; Uflex Ltd.; Clondalkin Group; Gualapack S.p.A.; Sharp Packaging Services; Ropack Pharma Solutions; Unither Pharmaceuticals; Tekni-Plex; Fresenius Kabi; Catalent, Inc.; Bemis Company, Inc.; AptarGroup, Inc.; Oliver Healthcare Packaging |
| Customization scope | Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Growth Catalysts & Market Constraints
The Sachet Packaging for Pharmaceuticals market is navigating a dynamic landscape, characterized by several influential factors that dictate its growth trajectory and overall industry expansion. Increasing demand for convenient and portable medication formats, driven by a globally aging population and busy lifestyles, serves as a significant impetus for market growth. Furthermore, the rising adoption of unit-dose packaging for enhanced patient compliance and reduced medication errors is positively impacting the Sachet Packaging for Pharmaceuticals market size. Technological advancements in material science, focusing on improved barrier properties and sustainable solutions, are also shaping the growth forecast. However, stringent regulatory frameworks and the need for high-quality, sterile packaging present both challenges and opportunities within this evolving sector.
Growth Drivers
- The escalating global demand for convenient, portable, and accurately dosed medication forms is a significant growth driver, fueled by an aging population and increasing prevalence of chronic diseases, making sachets ideal for daily regimens and on-the-go consumption, thereby enhancing patient adherence and therapeutic outcomes.
- Advancements in packaging materials, such as multi-layered films with superior barrier properties against moisture, oxygen, and light, ensure product stability and extend shelf life for sensitive pharmaceutical compounds, meeting stringent regulatory requirements and fostering market adoption across various drug formulations.
Restraints
- The high initial investment costs associated with specialized sachet packaging machinery and sophisticated automated production lines can deter smaller pharmaceutical manufacturers from adopting these solutions, limiting market penetration and potentially hindering overall market growth, especially in price-sensitive emerging economies.
- Stringent regulatory approval processes for pharmaceutical packaging materials, requiring extensive testing for material compatibility, stability, and child-resistance, often lead to prolonged development cycles and increased compliance costs, posing a significant barrier to innovation and rapid market entry for new packaging solutions.
Opportunities
- The increasing focus on sustainable packaging solutions presents a substantial opportunity for manufacturers to innovate with biodegradable, recyclable, or compostable sachet materials, aligning with global environmental initiatives and consumer preferences, which can open new market segments and enhance brand reputation.
- Expansion into emerging markets, particularly in Asia Pacific and Latin America, offers significant growth avenues due to rising healthcare expenditures, increasing access to pharmaceuticals, and a growing demand for cost-effective and convenient packaging formats, allowing for strategic partnerships and localized production.
Challenges
- Ensuring the integrity and sterility of pharmaceutical products within sachet packaging poses a critical challenge, as any breach in barrier properties or contamination during manufacturing can compromise drug efficacy and patient safety, necessitating rigorous quality control measures and advanced sealing technologies.
- Managing complex supply chains for specialized sachet materials, which often involve multiple suppliers and intricate lamination processes, can lead to vulnerabilities such as material shortages, price volatility, and logistical delays, impacting production schedules and overall operational efficiency for pharmaceutical companies.
Market Level Breakdown
The Sachet Packaging for Pharmaceuticals market is segmented by Material Type, including Plastic, Paper, Aluminum, and Others. Plastic materials, often used in multi-layered laminates, offer excellent barrier properties and flexibility, making them suitable for a wide range of pharmaceutical products. Paper-based sachets are gaining traction due to sustainability concerns, while aluminum foil provides superior protection against moisture and light for highly sensitive drugs. The 'Others' category encompasses innovative and composite materials tailored for specific drug requirements, contributing to the market's dynamic material landscape.
Product Type segmentation divides the market into Single-Dose Sachets and Multi-Dose Sachets. Single-dose sachets are highly preferred for ensuring precise medication dosage and enhancing patient compliance, especially for over-the-counter and prescription drugs requiring specific administration. Multi-dose sachets, while less common, cater to products where multiple doses are required in a single package or for bulk powders, offering convenience for specific therapeutic areas. This segmentation reflects varying patient needs and pharmaceutical formulation requirements.
By Application, the Sachet Packaging for Pharmaceuticals market is categorized into Powders, Granules, Liquids, and Pastes. Powders and granules represent the largest application segments due to the ease of packaging dry formulations and their stability benefits. Liquid and paste applications, though more challenging to package due to potential leakage and stability issues, are growing with advancements in barrier and sealing technologies. Each application demands specific material and structural properties to maintain product efficacy and safety, influencing packaging innovation.
The End-User segment includes Pharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Retail Pharmacies, and Hospitals & Clinics. Pharmaceutical companies are the primary end-users, both for in-house manufacturing and outsourcing to CMOs. CMOs play a crucial role by providing specialized packaging services, particularly for smaller firms or complex formulations. Retail pharmacies and hospitals & clinics primarily utilize pre-packaged sachets for dispensing and administration, driving demand for convenient, pre-measured units, contributing significantly to the Sachet Packaging for Pharmaceuticals segmentation.
Distribution Channel segmentation covers Direct Sales, Distributors, Online Retailers, and Others. Direct sales involve manufacturers selling directly to large pharmaceutical companies or CMOs. Distributors play a vital role in reaching a broader market, including smaller pharmacies and healthcare facilities. The rise of online pharmacies and healthcare platforms is boosting the online retailers segment, offering a convenient channel for patients to access sachet-packaged medications, impacting the overall market taxonomy.
Sachet Packaging for Pharmaceuticals Segmentation Breakdown
- Material Type
- Plastic
- Paper
- Aluminum Foil
- Others
- Product Type
- Single-use Sachets
- Multi-use Sachets
- Application
- Tablets & Capsules
- Powders
- Liquids
- Others
- End-User
- Hospitals
- Clinics
- Retail Pharmacies
- Others
- Distribution Channel
- Direct Sales
- Distributors
- Online Sales
- Others
Geographic Performance & Regional Trends
The global Sachet Packaging for Pharmaceuticals market exhibits significant regional disparities, with Asia Pacific emerging as the largest and fastest-growing market in 2025, accounting for an estimated 35% share. This dominance is primarily attributable to the region's burgeoning pharmaceutical manufacturing sector, expanding healthcare infrastructure, and a large population base with increasing access to medication. Countries like China and India are at the forefront of pharmaceutical production and consumption, driving demand for cost-effective and convenient packaging solutions. North America and Europe also hold substantial market shares, characterized by advanced healthcare systems, stringent regulatory standards, and a high adoption rate of innovative packaging technologies, though their growth rates are more moderate compared to Asia Pacific, influencing the Sachet Packaging for Pharmaceuticals market growth and regional forecast.
Regional Growth Drivers
- North America: The region benefits from a well-established pharmaceutical industry, high healthcare expenditure, and a strong emphasis on patient convenience and compliance. Regulatory support for unit-dose packaging and advanced manufacturing capabilities in the United States and Canada drive innovation and adoption of sachet solutions for diverse drug formulations.
- Europe: Stringent quality and safety regulations, coupled with an aging population, fuel demand for secure and convenient pharmaceutical packaging. Key markets like Germany, the United Kingdom, and France are investing in sustainable packaging materials and advanced barrier technologies to meet both regulatory and environmental objectives.
- Asia Pacific: Rapid industrialization, expanding pharmaceutical manufacturing bases in China and India, and increasing healthcare accessibility are propelling market growth. The large population and rising prevalence of chronic diseases drive the need for affordable and accessible medication, making sachet packaging a preferred choice.
- Latin America: Modernization of healthcare infrastructure and a growing focus on improving patient adherence are key drivers. Countries such as Brazil and Mexico are witnessing increased pharmaceutical production and consumption, leading to higher adoption of efficient packaging formats like sachets to cater to diverse patient needs.
- Middle East & Africa: Enhanced healthcare access, government initiatives to boost local pharmaceutical production, and increasing awareness about medication safety contribute to market expansion. Investments in healthcare infrastructure across countries like Saudi Arabia and South Africa are creating new opportunities for sachet packaging suppliers.
Looking ahead, while mature markets in North America and Europe will continue to innovate with advanced and sustainable sachet solutions, the significant growth impetus for the Sachet Packaging for Pharmaceuticals market will increasingly come from emerging economies. Asia Pacific, with its dynamic pharmaceutical landscape and vast consumer base, is expected to maintain its lead, offering substantial strategic implications for suppliers seeking to expand their global footprint. Latin America and MEA are also projected to present lucrative opportunities as their healthcare sectors evolve, necessitating localized strategies and flexible packaging solutions to meet diverse regional demands and regulatory nuances.
Competitive Insights & Leading Companies
The Sachet Packaging for Pharmaceuticals market is moderately consolidated, characterized by the presence of a few large, globally integrated players alongside numerous regional and specialized manufacturers. Global leaders like Amcor plc, Huhtamaki Group, and Mondi Group leverage extensive R&D capabilities, broad product portfolios, and global distribution networks to maintain their market dominance. These companies often offer a full spectrum of packaging solutions, from flexible films to finished sachets, catering to diverse pharmaceutical applications. Competitive intensity is driven by continuous innovation in material science, focusing on enhanced barrier properties, sustainability, and tamper-evident features. Pricing strategies are crucial, balancing cost-effectiveness for high-volume generics with premium offerings for specialty drugs. Regulatory approvals and certifications, such as FDA and EMA compliance, are non-negotiable entry barriers, ensuring product safety and efficacy. The Sachet Packaging for Pharmaceuticals competitive landscape is also shaped by regional players who often specialize in specific material types or product formats, offering tailored solutions and agile manufacturing processes to meet local market demands.
Key players in the Sachet Packaging for Pharmaceuticals market are actively pursuing various strategic initiatives to strengthen their market positions. Mergers and acquisitions are common, allowing companies to expand their geographical reach, acquire new technologies, or consolidate market share. For instance, integration of specialized film manufacturers by larger packaging conglomerates helps in vertical integration and control over the supply chain. Product launches focus on innovative materials, such as bio-based or recyclable films, and advanced sachet designs that improve user experience and product protection. Partnerships with pharmaceutical companies are critical for co-developing customized packaging solutions that meet specific drug stability and regulatory requirements. Differentiation often comes from specialized printing capabilities, anti-counterfeiting features, and comprehensive technical support. However, the market faces challenges such as margin pressure due to intense competition and rising raw material costs, as well as the need to continuously adapt to evolving regulatory landscapes, which necessitates significant investment in compliance and quality assurance. Supply chain risks, particularly for specialized barrier materials, also demand robust risk mitigation strategies.
Sachet Packaging for Pharmaceuticals Key Companies
- Amcor plc
- Constantia Flexibles Group GmbH
- Glenroy Inc.
- ProAmpac
- Huhtamaki Group
- Mondi Group
- Sealed Air Corporation
- Sonoco Products Company
- Uflex Ltd.
- Clondalkin Group
- Gualapack S.p.A.
- Sharp Packaging Services
- Ropack Pharma Solutions
- Unither Pharmaceuticals
- Tekni-Plex
- Fresenius Kabi
- Catalent, Inc.
- Bemis Company, Inc.
- AptarGroup, Inc.
- Oliver Healthcare Packaging
Sachet Packaging for Pharmaceuticals Market Ecosystem
Ecosystem Participants
- Raw Material Suppliers — Provide essential materials such as plastic polymers (polyethylene, polypropylene), aluminum foils, and specialty papers that form the foundational layers of sachet packaging. Their role is critical in ensuring the quality, barrier properties, and sustainability of the final product, directly impacting manufacturing costs and product performance.
- These suppliers must adhere to strict pharmaceutical-grade standards, often requiring certifications and rigorous testing to guarantee material purity and absence of contaminants, influencing the overall safety and regulatory compliance of packaged drugs.
- Packaging Film Manufacturers — Convert raw materials into specialized multi-layered films and laminates with specific barrier properties (e.g., moisture, oxygen, light). They innovate to create films that are compatible with various drug formulations and withstand diverse environmental conditions, crucial for drug stability.
- Their expertise in lamination, coating, and printing technologies directly impacts the functionality, aesthetic appeal, and branding opportunities for pharmaceutical sachets, ensuring high-quality output for downstream processes.
- Sachet Packaging Converters — Transform packaging films into finished sachets, performing processes like printing, slitting, forming, filling, and sealing. They often provide customized sachet designs and sizes, integrating features like easy-tear notches and child-resistant closures tailored to client specifications.
- These converters are responsible for the precision and integrity of the sachet, operating under strict GMP (Good Manufacturing Practices) to prevent contamination and ensure accurate filling, a crucial step before the product reaches pharmaceutical companies.
- Pharmaceutical Companies — The primary end-users of sachet packaging, utilizing these solutions for their diverse product portfolios including OTC drugs, prescription medications, and nutraceuticals. They drive demand based on product type, dosage requirements, and market strategy, influencing packaging innovation.
- Their collaboration with packaging providers is essential for developing solutions that meet stringent regulatory requirements, enhance patient compliance, and support brand differentiation in a competitive market, often demanding high levels of customization.
- Contract Manufacturing Organizations (CMOs) — Offer specialized manufacturing and packaging services to pharmaceutical companies, particularly those without in-house capabilities or needing to scale production. CMOs are key integrators, bridging drug formulation with efficient sachet packaging processes.
- CMOs ensure compliance with global regulatory standards, manage complex supply chains, and provide flexible production capacities, serving as a critical partner for many pharmaceutical firms seeking to optimize their operational efficiency and market reach.
- Regulatory Bodies & Standards Organizations — Establish and enforce guidelines for pharmaceutical packaging materials, manufacturing processes, and product labeling (e.g., FDA, EMA). Their role is to ensure product safety, quality, and efficacy throughout the supply chain.
- Compliance with these regulations is mandatory for all ecosystem participants, influencing material selection, production technologies, and quality control protocols, thus safeguarding public health and maintaining market integrity.
- Machinery and Equipment Providers — Supply the specialized filling, sealing, and inspection equipment necessary for efficient and high-volume sachet production. Their innovations in automation and precision machinery are vital for manufacturers.
- These providers contribute significantly to improving production speeds, reducing operational costs, and enhancing the overall quality and consistency of sachet packaging, directly impacting the scalability and efficiency of pharmaceutical packaging operations.
Report Coverage & Key Deliverables
The report delivers a comprehensive analysis of the Sachet Packaging for Pharmaceuticals, combining quantitative data with qualitative insights to provide a holistic understanding of the market landscape. It is meticulously designed to support strategic decision-making for stakeholders across the entire value chain, including pharmaceutical manufacturers, packaging suppliers, and investors. The study offers an in-depth examination of market trends, growth drivers, and challenges, enabling businesses to identify emerging opportunities and mitigate potential risks. By presenting a detailed market forecast, competitive intelligence, and regional breakdowns, the report equips users with actionable insights to formulate effective business strategies, optimize product portfolios, and enhance market penetration. Its comprehensive scope ensures that both established players and new entrants can gain a clear perspective on the industry's current state and future trajectory, facilitating informed investment and operational choices.
Report Coverage
- Market Size Estimates (historical and forecast)
- The report provides precise market size estimations for the Sachet Packaging for Pharmaceuticals market, spanning a historical period from 2021 to 2025 and a comprehensive forecast extending from 2026 to 2033. These figures are derived through a robust methodology involving primary and secondary research, including extensive interviews with industry experts and analysis of company reports and regulatory databases, ensuring accuracy and reliability.
- Detailed Segmentation And Revenue Analysis
- A granular breakdown of the market is offered across key segments such as Material Type, Product Type, Application, End-User, and Distribution Channel. Each segment is analyzed in terms of current market size and projected revenue growth, providing insights into the most lucrative sub-markets and enabling targeted strategic planning for product development and market entry.
- Regional And Country-Level Insights
- The study offers an exhaustive geographical analysis, covering major regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, with further breakdown into key countries. This section highlights regional market dynamics, growth rates, and regulatory landscapes, helping stakeholders understand market maturity and growth contrasts across different geographies.
- Competitive Benchmarking Of Key Players
- A thorough assessment of the competitive landscape includes profiles of leading companies, their strategic initiatives, product offerings, market shares, and recent developments. This benchmarking provides critical insights into the competitive intensity, market positioning, and differentiation strategies employed by key players, facilitating competitive intelligence and partnership opportunities.
- Customization Options Based on Specific Requirements
- The report offers flexible customization options to meet specific client needs, such as deeper dives into particular segments, additional country-level analysis, or detailed competitive profiling. This ensures that the deliverables are precisely tailored to address unique business questions and strategic objectives, providing maximum value.
Recent Industry Insights
The Sachet Packaging for Pharmaceuticals industry has witnessed a flurry of activities over the past 12-18 months, reflecting a strong emphasis on sustainability, technological advancements, and strategic expansions. Companies are increasingly investing in eco-friendly materials and designs, driven by regulatory pressures and consumer demand for greener solutions. There's a noticeable trend towards smart packaging features, such as QR codes and NFC tags, to enhance traceability and patient engagement. Several key players have engaged in strategic partnerships to broaden their product portfolios and geographical reach, particularly in emerging markets. Furthermore, product launches have focused on innovative barrier films that offer superior protection for sensitive drug formulations, addressing critical challenges in drug stability. These Sachet Packaging for Pharmaceuticals industry trends underscore a dynamic environment poised for continued evolution and growth.
Key Market Developments
- March 2024: Amcor plc announced a significant investment in sustainable packaging technologies, focusing on recyclable and compostable film solutions for pharmaceutical applications across its global operations.
- January 2024: Huhtamaki Group launched a new range of high-barrier, mono-material flexible packaging solutions designed to enhance the circularity of pharmaceutical sachets and reduce environmental impact.
- November 2023: ProAmpac expanded its manufacturing capabilities in North America to meet the growing demand for flexible packaging in the pharmaceutical sector, emphasizing advanced barrier films and custom sachet formats.
- September 2023: Constantia Flexibles Group GmbH introduced a new pharmaceutical sachet film with enhanced moisture barrier properties, specifically targeting hygroscopic drug formulations to improve product shelf life and stability.
- July 2023: Tekni-Plex acquired a specialized packaging company, bolstering its expertise in sterile and unit-dose packaging solutions for the pharmaceutical and medical device industries.
Analyst Opinion
The Sachet Packaging for Pharmaceuticals market presents an attractive investment landscape, driven by fundamental shifts in pharmaceutical consumption patterns and technological advancements. Market attractiveness remains high due to the increasing preference for convenient, unit-dose medications and the robust growth of the global pharmaceutical industry, particularly in generics and specialty drugs. The competitive intensity is moderately high, with established global players and agile regional manufacturers vying for market share through innovation in materials and packaging formats. While the supply side is well-equipped to meet current demands, the demand–supply balance is constantly influenced by regulatory changes, raw material availability, and geopolitical factors. Analysts project sustained growth, underpinned by the indispensable role of sachet packaging in ensuring drug efficacy, patient compliance, and supply chain efficiency, shaping a positive Sachet Packaging for Pharmaceuticals market outlook.
Looking at the long-term outlook, the Sachet Packaging for Pharmaceuticals market is poised for continued expansion, fueled by sustained R&D in sustainable and smart packaging solutions. The innovation landscape is rich, with ongoing developments in biodegradable films, advanced barrier coatings, and integrated digital features for enhanced traceability and anti-counterfeiting measures. Key risk factors include the volatile pricing of raw materials, increasing regulatory scrutiny on packaging waste, and the potential for supply chain disruptions, especially for specialized multi-layered films. However, strategic collaborations between pharmaceutical companies and packaging manufacturers, coupled with investments in automation and localized production, are expected to mitigate these risks. The market will also benefit from the expanding healthcare access in emerging economies, where cost-effective and efficient packaging solutions like sachets are crucial for widespread drug distribution and patient reach.